The coach serves as a support system and provides guidance for customers
Higher doses are associated with greater average A1C reductions and weight loss, but benefits may plateau as side effects increase
Retatrutide is the only medication ever tested that activates GLP-1, GIP, and glucagon receptors simultaneously
How to Talk to Your Doctor About GLP-1 and Dual GIP/GLP-1 Agonists for Obesity Before talking to your doctor about drugs for obesity and weight loss, its important to pause and reflect on your own comfort level, goals, resources, and support
GLP-1s do not cause any physiological dependence, and once-weekly GLP-1 medications, like Wegovy or Zepbound, have a long half-life in patients bodies, he says